AL-ALI (university of miami, school of medicine) - mcsp - exploratory chemistry (EC)
Ended Awarded Last action
- Contract number
- 75N95022F00002
- Awardee
-
Curia Global Inc. UEI ELCNZCS8GEA3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,173,499
Award facts
- Opportunity
-
- NIHNINDS2103 Solicitation number
- Contract value 100% obligated
- $3,173,498.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Albany, NY 12212, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $1,388,544 | |
| Exercise an Option | $1,223,763 | |
| Original award | $561,191 |
About this award
The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $3,173,498.83 cost-plus-fixed-fee Delivery Order contract to Curia Global Inc., doing business as Amri, for Exploratory Chemistry services under the Medicinal Chemistry Support Program for Therapeutic Development. The contract has a completion date of February 1, 2026 and does not have a small business set-aside designation. Curia, a global contract development and manufacturing organization, will provide a range of pharmaceutical research and development support services, including medicinal chemistry, chemical development, analytical testing, and good manufacturing practices production to support therapeutic development initiatives in areas such as Alzheimer's disease, Parkinson's disease, pain, stroke, substance abuse, and infectious diseases.
Quick answers
Who was awarded contract 75N95022F00002?
75N95022F00002 was awarded to Curia Global Inc. by National Institute on Drug Abuse (National Institutes of Health) on February 1, 2022.
How much is contract 75N95022F00002 worth?
The government has obligated $3,173,499 on 75N95022F00002.
Which agency awarded contract 75N95022F00002?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95022F00002, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Is contract 75N95022F00002 an order under another contract?
Yes. 75N95022F00002 is a delivery order under HHSN271201800001I, an indefinite delivery contract.
Was contract 75N95022F00002 competed?
The extent of competition for 75N95022F00002 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award